2BB score and signals
Pliant Therapeutics, Inc.’s current 2BB score is 31 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 27 | Low |
| Momentum | 34 | Weakening |
| Financial strength | 16 | Very Weak |
| Quality | 54 | Normal |
| Risk | 44 | Moderate |
Company facts
| Headquarters | South San Francisco, California, United States |
| Founded | 2015 |
| Employees | 49 |
| 52-week range | $0.88 – $1.95 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2027-03-09 | — | -0.3774 | — | $0.00 |
| 2026-11-05 | — | -0.3774 | — | $0.00 |
| 2026-08-10 | — | -0.3488 | — | $0.00 |
| 2026-05-11 | -0.32 | -0.3638 | $0.00 | $0.00 |
Related companies